Skip to menu Skip to content Skip to footer

2022

Journal Article

Dynamic insulin-stimulated mTOR/GSK3 signaling in peripheral immune cells: preliminary evidence for an association with lithium response in bipolar disorder

Tye, Susannah J., Borreggine, Kristin, Price, J. Blair, Sutor, Shari L., Cuéllar-Barboza, Alfredo B., McElroy, Susan L., Biernacka, Joanna M. and Frye, Mark A. (2022). Dynamic insulin-stimulated mTOR/GSK3 signaling in peripheral immune cells: preliminary evidence for an association with lithium response in bipolar disorder. Bipolar Disorders, 24 (1) bdi.13081, 1-9. doi: 10.1111/bdi.13081

Dynamic insulin-stimulated mTOR/GSK3 signaling in peripheral immune cells: preliminary evidence for an association with lithium response in bipolar disorder

2021

Journal Article

Lithium augmentation of ketamine increases insulin signaling and antidepressant-like active stress coping in a rodent model of treatment-resistant depression

Price, J. Blair, Yates, Clarissa G., Morath, Brooke A., Van De Wakker, Sam K., Yates, Nathanael J., Butters, Kim, Frye, Mark A., McGee, Sean L. and Tye, Susannah J. (2021). Lithium augmentation of ketamine increases insulin signaling and antidepressant-like active stress coping in a rodent model of treatment-resistant depression. Translational Psychiatry, 11 (1) 598, 598. doi: 10.1038/s41398-021-01716-w

Lithium augmentation of ketamine increases insulin signaling and antidepressant-like active stress coping in a rodent model of treatment-resistant depression

2021

Journal Article

Modulating neuroplasticity: lessons learned from antidepressants and emerging novel therapeutics

Yates, Clarissa, Kruse, Jennifer L., Price, J. Blair, Robertson, Avril A. B. and Tye, Susannah J. (2021). Modulating neuroplasticity: lessons learned from antidepressants and emerging novel therapeutics. Current Treatment Options in Psychiatry, 8 (4), 229-257. doi: 10.1007/s40501-021-00249-9

Modulating neuroplasticity: lessons learned from antidepressants and emerging novel therapeutics

2021

Journal Article

Interleukin-8 and lower severity of depression in females, but not males, with treatment-resistant depression

Kruse, Jennifer L., Olmstead, Richard, Hellemann, Gerhard, Breen, Elizabeth C., Tye, Susannah J., Brooks, John O., Wade, Benjamin, Congdon, Eliza, Espinoza, Randall, Narr, Katherine L. and Irwin, Michael R. (2021). Interleukin-8 and lower severity of depression in females, but not males, with treatment-resistant depression. Journal of Psychiatric Research, 140, 350-356. doi: 10.1016/j.jpsychires.2021.06.009

Interleukin-8 and lower severity of depression in females, but not males, with treatment-resistant depression

2021

Journal Article

Mood regulatory actions of active and sham nucleus accumbens deep brain stimulation in antidepressant resistant rats

Kale, Rajas P., Nguyen, Thanh Thanh L., Price, J. Blair, Yates, Nathanael J., Walder, Ken, Berk, Michael, Sillitoe, Roy V., Kouzani, Abbas Z. and Tye, Susannah J. (2021). Mood regulatory actions of active and sham nucleus accumbens deep brain stimulation in antidepressant resistant rats. Frontiers in Human Neuroscience, 15 644921, 644921. doi: 10.3389/fnhum.2021.644921

Mood regulatory actions of active and sham nucleus accumbens deep brain stimulation in antidepressant resistant rats

2021

Journal Article

Cocaine-induced changes in tonic dopamine concentrations measured using multiple-cyclic square wave voltammetry in vivo

Yuen, Jason, Goyal, Abhinav, Rusheen, Aaron E., Kouzani, Abbas Z., Berk, Michael, Kim, Jee Hyun, Tye, Susannah J., Blaha, Charles D., Bennet, Kevin E., Jang, Dong-Pyo, Lee, Kendall H., Shin, Hojin and Oh, Yoonbae (2021). Cocaine-induced changes in tonic dopamine concentrations measured using multiple-cyclic square wave voltammetry in vivo. Frontiers in Pharmacology, 12 705254, 705254. doi: 10.3389/fphar.2021.705254

Cocaine-induced changes in tonic dopamine concentrations measured using multiple-cyclic square wave voltammetry in vivo

2021

Journal Article

Inflammatory mechanisms in Parkinson’s disease: from pathogenesis to targeted therapies

Lee, Stellina Y. H., Yates, Nathanael J. and Tye, Susannah J. (2021). Inflammatory mechanisms in Parkinson’s disease: from pathogenesis to targeted therapies. The Neuroscientist, 28 (5) 1073858421992265, 1073858421992265-506. doi: 10.1177/1073858421992265

Inflammatory mechanisms in Parkinson’s disease: from pathogenesis to targeted therapies

2021

Journal Article

Novel antidepressant approaches for refractory depression

Postorivo, Danielle and Tye, Susannah J. (2021). Novel antidepressant approaches for refractory depression. Current Treatment Options in Psychiatry, 8 (3), 141-157. doi: 10.1007/s40501-021-00246-y

Novel antidepressant approaches for refractory depression

2020

Journal Article

Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression

Shiroma, Paulo R., Thuras, Paul, Wels, Joseph, Albott, C. Sophia, Erbes, Christopher, Tye, Susannah and Lim, Kelvin O. (2020). Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression. Journal of Affective Disorders, 277, 470-477. doi: 10.1016/j.jad.2020.08.058

Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression

2020

Journal Article

Role of epigenetic regulatory enzymes in animal models of mania induced by amphetamine and paradoxical sleep deprivation

Varela, Roger B., Resende, Wilson R., Dal-Pont, Gustavo C., Gava, Fernanda F., Nadas, Gabriella B., Tye, Susannah J., Andersen, Monica L., Quevedo, João and Valvassori, Samira S (2020). Role of epigenetic regulatory enzymes in animal models of mania induced by amphetamine and paradoxical sleep deprivation. European Journal of Neuroscience, 53 (2) ejn.14922, 649-662. doi: 10.1111/ejn.14922

Role of epigenetic regulatory enzymes in animal models of mania induced by amphetamine and paradoxical sleep deprivation

2020

Journal Article

A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression

Shiroma, Paulo R., Thuras, Paul, Wels, Joseph, Albott, C Sophia, Erbes, Christopher, Tye, Susannah and Lim, Kelvin O. (2020). A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression. Translational Psychiatry, 10 (1) 206, 206. doi: 10.1038/s41398-020-00897-0

A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression

2020

Journal Article

HDAC inhibitors reverse mania-like behavior and modulate epigenetic regulatory enzymes in an animal model of mania induced by Ouabain

Varela, Roger B., Resende, Wilson R., Dal-Pont, Gustavo C., Gava, Fernanda F., Tye, Susannah J., Quevedo, João and Valvassori, Samira S. (2020). HDAC inhibitors reverse mania-like behavior and modulate epigenetic regulatory enzymes in an animal model of mania induced by Ouabain. Pharmacology Biochemistry and Behavior, 193 172917, 172917. doi: 10.1016/j.pbb.2020.172917

HDAC inhibitors reverse mania-like behavior and modulate epigenetic regulatory enzymes in an animal model of mania induced by Ouabain

2020

Journal Article

Feasibility study of Stress Management and Resiliency Training (SMART) in patients with major depressive disorder

Seshadri, Ashok, Clark, Matthew M., Kung, Simon, Fuller-Tyszkiewicz, Matthew, Sood, Amit, Dammen, Kristina C., Rico, Jose A., Tye, Susannah J., McGillivray, Jane and Frye, Mark A. (2020). Feasibility study of Stress Management and Resiliency Training (SMART) in patients with major depressive disorder. Primary Care Companion to CNS Disorders, 22 (3) 19m02556. doi: 10.4088/PCC.19m02556

Feasibility study of Stress Management and Resiliency Training (SMART) in patients with major depressive disorder

2020

Journal Article

TinyFSCV: FSCV for the masses

Adams, Scott D., Doeven, Egan H., Tye, Susannah J., Bennet, Kevin E., Berk, Michael and Kouzani, Abbas Z. (2020). TinyFSCV: FSCV for the masses. IEEE Transactions on Neural Systems and Rehabilitation Engineering, 28 (1) 8917694, 133-142. doi: 10.1109/TNSRE.2019.2956479

TinyFSCV: FSCV for the masses

2020

Journal Article

Brain entropy and neurotrophic molecular markers accompanying clinical improvement after ketamine: preliminary evidence in adolescents with treatment-resistant depression

Roy, Abhrajeet V., Thai, Michelle, Klimes-Dougan, Bonnie, Westlund Schreiner, Mindy, Mueller, Bryon A., Albott, Christina Sophia, Lim, Kelvin O., Fiecas, Mark, Tye, Susannah J. and Cullen, Kathryn R. (2020). Brain entropy and neurotrophic molecular markers accompanying clinical improvement after ketamine: preliminary evidence in adolescents with treatment-resistant depression. Journal of Psychopharmacology, 35 (2), 026988112092820-177. doi: 10.1177/0269881120928203

Brain entropy and neurotrophic molecular markers accompanying clinical improvement after ketamine: preliminary evidence in adolescents with treatment-resistant depression

2019

Journal Article

Insulin-stimulated mTOR activation in peripheral blood mononuclear cells associated with early treatment response to lithium augmentation in rodent model of antidepressant-resistance

Walker, Adam J., Price, J. Blair, Borreggine, Kristin, Sutor, Shari L., Gogos, Andrea, McGillivray, Jane A., Frye, Mark A. and Tye, Susannah J. (2019). Insulin-stimulated mTOR activation in peripheral blood mononuclear cells associated with early treatment response to lithium augmentation in rodent model of antidepressant-resistance. Translational Psychiatry, 9 (1) 113, 113. doi: 10.1038/s41398-019-0434-5

Insulin-stimulated mTOR activation in peripheral blood mononuclear cells associated with early treatment response to lithium augmentation in rodent model of antidepressant-resistance

2019

Journal Article

Development of a miniature device for emerging deep brain stimulation paradigms

Adams, Scott D., Bennet, Kevin E., Tye, Susannah J., Berk, Michael and Kouzani, Abbas Z. (2019). Development of a miniature device for emerging deep brain stimulation paradigms. PLoS ONE, 14 (2) e0212554, e0212554. doi: 10.1371/journal.pone.0212554

Development of a miniature device for emerging deep brain stimulation paradigms

2019

Journal Article

The role of neurotrophic factors in manic-, anxious- and depressive-like behaviors induced by amphetamine sensitization: implications to the animal model of bipolar disorder

Valvassori, Samira S., Mariot, Edemilson, Varela, Roger B., Bavaresco, Daniela V., Dal-Pont, Gustavo C., Ferreira, Camila L., Andersen, Monica L., Tye, Susannah J. and Quevedo, João (2019). The role of neurotrophic factors in manic-, anxious- and depressive-like behaviors induced by amphetamine sensitization: implications to the animal model of bipolar disorder. Journal of Affective Disorders, 245, 1106-1113. doi: 10.1016/j.jad.2018.10.370

The role of neurotrophic factors in manic-, anxious- and depressive-like behaviors induced by amphetamine sensitization: implications to the animal model of bipolar disorder

2019

Journal Article

Erratum: Intravenous ketamine for adolescents with treatment-resistant depression: An Open-Label Study, by Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y, Eberly LE, Carstedt P, Samikoglu A, Gunlicks-Stoessel M, Reigstad K, Horek N, Tye S, Lim KO, Klimes-Dougan B. (J Child Adolesc Psychopharmacol (2018) 28:7 (437-444) DOI: 10.1089/cap.2018.0030)

Cullen, K. R., Amatya, P., Roback, M. G., Albott, C. S., Westlund Schreiner, M., Ren, Y., Eberly, L. E., Carstedt, P., Samikoglu, A., Gunlicks-Stoessel, M., Reigstad, K., Horek, N., Tye, S., Lim, K. O. and Klimes-Dougan, B. (2019). Erratum: Intravenous ketamine for adolescents with treatment-resistant depression: An Open-Label Study, by Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y, Eberly LE, Carstedt P, Samikoglu A, Gunlicks-Stoessel M, Reigstad K, Horek N, Tye S, Lim KO, Klimes-Dougan B. (J Child Adolesc Psychopharmacol (2018) 28:7 (437-444) DOI: 10.1089/cap.2018.0030). Journal of Child and Adolescent Psychopharmacology, 29 (1), 77-77. doi: 10.1089/cap.2018.0030.correx

Erratum: Intravenous ketamine for adolescents with treatment-resistant depression: An Open-Label Study, by Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y, Eberly LE, Carstedt P, Samikoglu A, Gunlicks-Stoessel M, Reigstad K, Horek N, Tye S, Lim KO, Klimes-Dougan B. (J Child Adolesc Psychopharmacol (2018) 28:7 (437-444) DOI: 10.1089/cap.2018.0030)

2018

Journal Article

Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders

Ahmed, T. Ahmed, Frye, Mark A., Rush, A. John, Biernacka, Joanna M., Craighead, W. Edward, McDonald, William M., Bobo, William V., Riva-Posse, Patricio, Tye, Susannah J., Mayberg, Helen S., Hall-Flavin, Daniel K., Skime, Michelle K., Jenkins, Greg D., Wang, Liewei, Krishnan, Ranga Rama, Weinshilboum, Richard M., Kaddurah-Daouk, Rima and Dunlop, Boadie W. (2018). Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders. Journal of Affective Disorders, 238, 1-7. doi: 10.1016/j.jad.2018.05.005

Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders